Exosome‑derived microRNA‑433 inhibits tumorigenesis through incremental infiltration of CD4 and CD8 cells in non‑small cell lung cancer-Reference-Cited by-同舟云学术

Exosome‑derived microRNA‑433 inhibits tumorigenesis through incremental infiltration of CD4 and CD8 cells in non‑small cell lung cancer

Published:2021-06-15 Issue:2 Volume:22 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Liu Boyang¹,Zhang Ruiping²,Zhu Yungang³,Hao Ruisheng¹

Affiliation:

1. Department of Radiation, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China

2. Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China

3. Department of Radiation Oncology, Tianjin Teda Hospital, Tianjin 300457, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular Vesicle microRNA: A Promising Biomarker and Therapeutic Target for Respiratory Diseases;International Journal of Molecular Sciences;2024-08-23

2. MicroRNA-based interventions in aberrant cell cycle diseases: Therapeutic strategies for cancers, central nervous system disorders and comorbidities;Biomedicine & Pharmacotherapy;2024-08

3. MiRNAs and Microbiota in Non-Small Cell Lung Cancer (NSCLC): Implications in Pathogenesis and Potential Role in Predicting Response to ICI Treatment;International Journal of Molecular Sciences;2024-06-18

4. Extracellular vesicles mediated gastric cancer immune response: tumor cell death or immune escape?;Cell Death & Disease;2024-05-30

5. Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy;Journal of Cardiothoracic Surgery;2024-03-11